Close
Patheon

News Releases

  • 01 Feb 2017

    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, South Carolina from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network. The site adds a 300,000 square-foot facility with manufacturingmore...
  • 28 Nov 2016

    Company Gains Additional API Capacity and Major Supply Agreement with Roche

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. ("Patheon" or the "company") (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, South Carolina, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltdmore...
  • 11 Oct 2016

    Company Commences Search for a New CFO

    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE:PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, today announced that its executive vice president and chief financial officer, Stuart Grant, plans to retire in 2017. Grant will remain in his current role until a successor has been appointed and a transition has been completed. The company has initiated a search to identify amore...